Initial Laboratory Assessment for Pituitary Mass
Essential Laboratory Tests
- The American Association of Neurological Surgeons recommends that all patients with a pituitary mass should undergo comprehensive endocrine evaluation of all anterior pituitary axes to assess for both hormone hypersecretion and hypopituitarism, including prolactin, IGF-1, thyroid function, adrenal function, and gonadal function 1, 2, 3
- Prolactin levels should be measured in all patients regardless of symptoms, as hyperprolactinemia occurs in 25-65% of nonfunctioning adenomas due to stalk compression, with levels >200 ng/mL suggesting prolactinoma 1, 3
- Insulin-like Growth Factor 1 (IGF-1) should be obtained in all patients to screen for clinically silent growth hormone hypersecretion, as up to 45% of presumed nonfunctioning adenomas show GH immunostaining without clinical acromegaly 1, 2
Hypopituitarism Assessment
- The prevalence of hypopituitarism in pituitary masses is substantial (37-85% have at least one axis deficiency), making comprehensive screening essential, with thyroid axis evaluation using TSH and free T4 to detect central hypothyroidism (present in 8-81% of patients) 1, 2, 3
- Adrenal axis evaluation using morning cortisol (8 AM) ± ACTH is necessary to assess for adrenal insufficiency (present in 17-62% of patients), with cortisol <3 μg/dL indicating deficiency; >15 μg/dL excludes it, and values between 3-15 μg/dL require ACTH stimulation testing 1, 2
- Gonadal axis evaluation is necessary, with morning testosterone, LH, and FSH measured in men (hypogonadism present in 36-96% of male patients), and LH, FSH, estradiol measured in women (hypogonadism present in 36-96% of patients) 1, 2, 4
Critical Pitfalls to Avoid
- The American Association of Neurological Surgeons recommends that symptoms alone should not be relied upon to guide hormone testing, as many hormone deficiencies and excesses are clinically silent, particularly GH excess and early hypopituitarism 1, 2
- Adrenal and thyroid function should always be assessed preoperatively in macroadenomas, as unrecognized deficiencies can cause perioperative complications 1